Endoscopic radiofrequency to reduce blood transfusions in GAVE
Part of Digestive system, Heart & circulation clinical trials.
This trial tests a treatment called endoscopic radiofrequency, which uses heat to stop bleeding from abnormal blood vessels in the stomach (a condition called GAVE). It aims to reduce the need for blood transfusions and improve anemia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of GAVE (a stomach condition that can cause bleeding).
- You must have had symptoms like black stools, vomiting blood, or anemia that persists despite iron treatment for at least 6 months.
- You must have had a colonoscopy in the past year that showed no other source of bleeding.
- You must not have other causes of anemia, active cancer, or a bleeding disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a freezing spray (Tru-Freeze) to treat GAVE, a condition that causes stomach bleeding. It may help people who need blood transfusions because of GAVE and have had few or no prior endoscopic treatments.
This trial compares two treatments for anemia caused by GAVE, a condition with bleeding stomach blood vessels. It tests a medication (thalidomide) against a procedure (argon plasma coagulation) to see which is better at improving anemia in people with cirrhosis.
This trial tests a new endoscopic procedure called anti-reflux mucosal ablation therapy to reduce acid reflux in people who still have symptoms despite taking acid-reducing medication. The goal is to see if this treatment helps improve heartburn and related symptoms.
This study tests whether a treatment called radiofrequency ablation (using heat energy to remove abnormal tissue) can help people with severe stomach lining thinning and early pre-cancer changes. It is an observational study, meaning the researchers will watch what happens to you while you get the treatment, to see if it is safe and works.
This study looks at people with a stomach condition called gastric antral vascular ectasia (GAVE) to understand how it affects digestion and causes symptoms. Researchers want to learn if stomach muscle function problems are common in this condition.
This trial studies better ways to use endoscopy and other treatments to stop bleeding in the stomach or esophagus caused by high blood pressure in the liver (portal hypertension). It may help if you have been diagnosed with portal hypertension and have varices (enlarged veins) in your esophagus or stomach.
Hear when a new GAVE - Gastric Antral Vascular Ectasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.